amlexanox has been researched along with Fatty Liver, Nonalcoholic in 3 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Non-alcoholic fatty liver disease (NAFLD) was associated with increased level of lipopolysaccharides (LPS) which mechanism remained unclear on intervention between LPS and NAFLD." | 1.56 | Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling. ( He, Q; Tang, R; Wang, W; Wu, Q; Xia, X; Yao, K; Zeng, J; Zou, X, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q | 2 |
| Xia, X | 2 |
| Yao, K | 2 |
| Zeng, J | 2 |
| Wang, W | 2 |
| Wu, Q | 2 |
| Tang, R | 2 |
| Zou, X | 2 |
| Oral, EA | 1 |
| Reilly, SM | 1 |
| Gomez, AV | 1 |
| Meral, R | 1 |
| Butz, L | 1 |
| Ajluni, N | 1 |
| Chenevert, TL | 1 |
| Korytnaya, E | 1 |
| Neidert, AH | 1 |
| Hench, R | 1 |
| Rus, D | 1 |
| Horowitz, JF | 1 |
| Poirier, B | 1 |
| Zhao, P | 1 |
| Lehmann, K | 1 |
| Jain, M | 1 |
| Yu, R | 1 |
| Liddle, C | 1 |
| Ahmadian, M | 1 |
| Downes, M | 1 |
| Evans, RM | 1 |
| Saltiel, AR | 1 |
1 trial available for amlexanox and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.
Topics: Aged; Aminopyridines; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Metaboli | 2017 |
2 other studies available for amlexanox and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
Topics: Actins; Aminopyridines; Animals; Body Weight; Energy Metabolism; Gene Expression; Glucose; Hepatic S | 2019 |
Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
Topics: Aminopyridines; Animals; Diet, High-Fat; Disease Models, Animal; Gene Expression; I-kappa B Kinase; | 2020 |